4VP-53584-65859
3 vaccinations
4 coded responses
34 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 980 / WA
- Registered
- 2022-06-20
- Relationship
- Child or adolescent in my care
- Guardian
- G27-25385-53121
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-20
Registered in v-safe
-
2022-06-24
Dose 1 — Moderna
-
2022-06-25
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Pain · NoneUnder 3 check-in
- 2022-06-26
- 2022-06-27
- 2022-06-28
- 2022-06-29
- 2022-06-30
- 2022-07-01
- 2022-07-08
- 2022-07-17
-
2022-07-22
Dose 2 — Moderna
- 2022-07-22
-
2022-07-23
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Site: Pain · Fever · Irritability/cryingUnder 3 check-in
- 2022-07-24
- 2022-07-25
- 2022-07-26
- 2022-07-27
- 2022-07-29
- 2022-08-05
- 2022-08-12
- 2022-08-19
- 2022-08-28
- 2022-09-04
-
2022-10-23
Survey response — 3 months, dose 2, under 3MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-12-17
Dose 3 — Moderna
-
2022-12-20
Health check-in — days 1–6 daily, dose 3, under 3Feeling: Poor · Fever · Irritability/crying · Be unable to do your normal daily activitiesUnder 3 check-in
-
2022-12-21
Survey response — days 1–6 daily, dose 3, under 3MedDRA: Constipation — Feeling: Poor · Fever · Irritability/cryingFree text: ConstipationMedDRA releases: 2024-11 · check-in free text available
-
2022-12-22
Health check-in — days 1–6 daily, dose 3, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
-
2022-12-23
Health check-in — days 1–6 daily, dose 3, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-12-24
- 2023-01-02
-
2023-01-07
Survey response — day 21, dose 3, under 3MedDRA: Rhinorrhoea — Feeling: GoodMedDRA releases: 2024-11
- 2023-01-14
- 2023-01-21
-
2023-01-28
Survey response — day 42, dose 3, under 3MedDRA: Rhinorrhoea — Feeling: GoodMedDRA releases: 2024-11
- 2023-03-18
- 2023-06-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-24 | Moderna | No |
| 2 | 2022-07-22 | Moderna | No |
| 3 | 2022-12-17 | Moderna | No |
Free text
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: Runny nose
Release 12 (Under 3) — days 1–6 daily, dose 3, under 3
Systemic reaction (other): Constipation
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Constipation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release